SPC
NVAX icon

Sigma Planning Corp’s Novavax NVAX Stock Holding History

Sigma Planning Corp’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,108
Closed -$87.6K – 1363
2025
Q3 		$87.6K Buy
+10,108
New +$78.7K ﹤0.01% 1261
2022
Q1 		– Sell
-1,685
Closed -$241K – 1458
2021
Q4 		$241K Buy
1,685
+355
+27% +$61K 0.01% 1191
2021
Q3 		$276K Buy
1,330
+110
+9% +$24.2K 0.01% 1101
2021
Q2 		$259K Buy
+1,220
New +$224K 0.01% 1165
2021
Q1 		– Sell
-2,559
Closed -$285K – 1383
2020
Q4 		$285K Buy
2,559
+620
+32% +$65.9K 0.01% 925
2020
Q3 		$210K Sell
1,939
-781
-29% -$95.1K 0.01% 942
2020
Q2 		$227K Buy
+2,720
New +$104K 0.01% 891

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sigma Planning Corp's NVAX Position: Q4 2025 in Review

Sigma Planning Corp sold out of Novavax (NVAX) in Q4 2025, closing a stake of 10,108 shares — an estimated $87.6K sold.

Sigma Planning Corp first reported a position in NVAX in Q2 2020 and held it in 7 quarters. The position peaked at $285K in Q4 2020. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

  • Sigma Planning Corp reported no remaining Novavax position as of Q4 2025 after selling out during the quarter.
  • Sigma Planning Corp sold 10,108 Novavax shares in Q4 2025, an estimated $87.6K.
  • Sigma Planning Corp first reported a position in Novavax in Q2 2020 and held it in 7 quarters.
  • Sigma Planning Corp's Novavax position peaked at $285K in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on Sigma Planning Corp's 13F filing for Q4 2025, filed 30 Jan 2026.